POSSIBLE BENEFIT OF GR43175, A NOVEL 5-HT1-LIKE RECEPTOR AGONIST, FOR THE ACUTE TREATMENT OF SEVERE MIGRAINE
Open Access
- 1 June 1988
- journal article
- research article
- Published by Elsevier in The Lancet
- Vol. 331 (8598) , 1309-1311
- https://doi.org/10.1016/s0140-6736(88)92122-8
Abstract
No abstract availableThis publication has 8 references indexed in Scilit:
- Proposals for the classification and nomenclature of functional receptors for 5-hydroxytryptamineNeuropharmacology, 1986
- Functional Bases for a Central Serotonergic Involvement in Classic Migraine: A Speculative ViewCephalalgia, 1985
- 5‐Carboxamide tryptamine, a compound with high affinity for 5‐hydroxytryptamine! binding sites, dilates arterioles and constricts arteriovenous anastomosesBritish Journal of Pharmacology, 1985
- IMMUNOHISTOCHEMICAL DEMONSTRATION OF SEROTONIN IN NERVES SUPPLYING HUMAN CEREBRAL AND MESENTERIC BLOOD-VESSELSThe Lancet, 1983
- The Action of Ergotamine on the Distribution of Carotid Blood Flow ‐ the Migraine Shunt Theory RevisitedHeadache: The Journal of Head and Face Pain, 1980
- Plasma Serotonin in Migraine and StressArchives of Neurology, 1967
- Biochemical Investigations in Headache: Increase in the Hydroxyindoleacetic Acid Excretion During Migraine AttacksInternational Archives of Allergy and Immunology, 1961
- Effect of serotonin in migraine patientsNeurology, 1960